Singapore-based healthcare startup TeleMedC has formed a partnership with the Department of Ophthalmology at the University Medical Centre Hamburg-Eppendorf (UKE) in Hamburg, Germany, media reports said. Through the partnership, both partis will work towards the detection and grading of cataracts with the automated diagnosis of the most common retinal diseases, including glaucoma.
TeleMedC provides low-cost diagnostic solutions for point-of-care screening and virtual management of eye and chronic diseases. This partnership was enabled and facilitated by Scaler8, a market expansion partner specialised in positioning Asian startups in Germany.
Dr Martin Spitzer, a professor of Ophthalmology and Head of Department at the UK told the media, “This cutting-edge project has the potential to cover a wider scope as it combines the detection and grading of cataracts – the globally leading cause of blindness – as well as the automated diagnosis of glaucoma and other common retinal diseases. It will cover most diseases that could lead to blindness and could even support the non-invasive detection of other non-eye diseases. We wholeheartedly support this exciting cooperative R&D project with TeleMedC and reiterate our commitment to contributing our expertise.”
Recently, it was reported that Singapore-based healthtech startup Mesh Bio raised around $1.8 million in a funding round. The funding round for the startup was led by deeptech investor Elev8.vc and SEEDS Capital, the investment arm of Enterprise Singapore. Other investors that also participated in the funding round for Mesh Bio includes Wealth management firm Citrine Capital as well as Singaporean VC firm Tael Partners.